Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physician Initiated, Prospective, Non-Randomized Single-Center Trial, Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore

NCT04071782 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT04071782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physician Initiated, Prospective, Non-Randomized Single-Center Trial, Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore
Lead sponsor
Singapore General Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 8, 2019
Completion date
January 30, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia